Skip to main content

Table 2 Values of parameters in the different groups of patients with liver disease and in controls

From: The expression levels of prolyl oligopeptidase responds not only to neuroinflammation but also to systemic inflammation upon liver failure in rat models and cirrhotic patients

Parameter

Controls

Patients without MHE (p vs. control)

Patients with MHE (p vs. control)

p values (without MHE vs. with MHE)

Global ANOVA

p values

PHES

−0.2 ± 0.8a

−0.4 ± 0.8

−6 ± 2

<0.001

<0.0001

p < 0.001

Nitrates + Nitrites (μM)

18 ± 3

24 ± 8

29 ± 8

ns

<0.0001

p < 0.05

p < 0.001

cGMP in Plasma (pmoles/ml)

4 ± 1

7 ± 3

10 ± 4

<0.05

<0.0001

p < 0.05

p < 0.001

Lymphocyte basal cGMP (pmol/mg prot)

0.169 ± 0.06

0.078 ± 0.06

0.047 ± 0.02

ns

<0.0001

p < 0.001

p < 0.01

SNAP-induced cGMP increase (fold)

11 ± 3

21 ± 9

22 ± 11

ns

0.0004

p < 0.01

p < 0.01

ANP (ng/ml)

0.014 ± 0.003

0.015 ± 0.002

0.015 ± 0.002

ns

ns

IL-6 (pg/ml)

1 ± 0.6

2.5 ± 1.5

4.7 ± 2.1

<0.001

<0.0001

p < 0.05

p < 0.001

IL-18 (pg/ml)

174 ± 80

281 ± 138

388 ± 138

<0.05

<0.0001

p < 0.05

p < 0.001

Creatinine (mg/dl)

0.74 ± 0.12

0.77 ± 0.19

0.86 ± 0.45

ns

ns

Total bilirubin (mg/dl)

0.61 ± 0.16

1.42 ± 0.94

1.05 ± 0.83

ns

0.005

p = 0.003

Albumin (g/dl)

4.49 ± 0.14

3.90 ± 0.56

3.70 ± 0.59

ns

<0.001

p = 0.001

p < 0.001

INR

1.06 ± 0.05

1.22 ± 0.36

1.18 ± 0.17

ns

0.08

Ammonia (μM)

72 ± 22

127 ± 40

131 ± 35

ns

<0.001

p < 0.001

p < 0.001

  1. Differences between groups were assessed with ANOVA plus post hoc Tukey test
  2. MHE minimal hepatic encephalopathy, PHES Psychometric Hepatic Encephalopathy Score, ANP atrial natriuretic peptide, IL-6 interleukin-6, IL-18 interleukin-18
  3. aValues are expressed as the mean ± SD